AnalystsDavid Dai
David Dai's Stock Forecasts

Analyst Ranking
Bottom 5%
#4663 out of 4870 analysts
Average Return
-30.67%
Win Rate
11%2 out of 19
Risk vs Reward
Poor
Good

David Dai's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Jdcom IncJD
+122.61%$38.35$85.37
2020-03-17 -
2021-03-17
Buy
Immunocore Holdings PLCIMCR
+7.23%$32.50$30.15
2024-10-24 -
2025-05-01
Strong Sell

David Dai Analyst Color

Get additional color on David Dai's coverage of popular stocks

David Dai's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nuvalent IncNUVL
2Strong Buy$100.00+31.18%Upgrades
2 months ago
Kura Oncology IncKURA
2Strong Buy$14.00+115.72%Maintains
2 months ago
Immunocore Holdings PLCIMCR
1Strong Sell$24.00-20.40%Initiates Coverage On
6 months ago
Blueprint Medicines CorpBPMC
1Hold$88.00-11.34%Initiates Coverage On
6 months ago
Perspective Therapeutics IncCATX
1Strong Buy$20.00+709.72%Initiates Coverage On
6 months ago
Nurix Therapeutics IncNRIX
1Strong Buy$35.00+213.62%Initiates Coverage On
6 months ago
Merus NvMRUS
1Strong Buy$72.00+58.42%Initiates Coverage On
6 months ago
Janux Therapeutics IncJANX
1Strong Buy$69.00+115.29%Initiates Coverage On
6 months ago
Ideaya Biosciences IncIDYA
1Strong Buy$50.00+144.26%Initiates Coverage On
6 months ago
Iovance Biotherapeutics IncIOVA
1Strong Buy$17.00+410.51%Initiates Coverage On
6 months ago
Cullinan Therapeutics IncCGEM
1Strong Buy$30.00+252.11%Initiates Coverage On
6 months ago
Cg Oncology IncCGON
1Strong Buy$60.00+116.29%Initiates Coverage On
6 months ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$37.00+167.73%Initiates Coverage On
6 months ago
Adicet Bio IncACET
1Buy$28.00N/AInitiates Coverage On
3 years ago
Jounce Therapeutics IncJNCE
1Buy$17.00N/AInitiates Coverage On
3 years ago
Inhibrx IncINBX1
1Buy$40.00N/AInitiates Coverage On
3 years ago
Macrogenics IncMGNX
1Buy$40.00N/AInitiates Coverage On
3 years ago
Nkarta IncNKTX
1Buy$50.00N/AInitiates Coverage On
3 years ago
Jdcom IncJD
1Buy$52.00N/AUpgrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.